WILMINGTON, Mass.--(BUSINESS WIRE)--Sept. 22, 2006--Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has been awarded a ten year, $111.6 million contract by the National Cancer Institute (NCI), more than doubling the size of its current contract with NCI. For the last twelve years, Charles River has provided onsite staffing support to NCI’s Frederick Cancer Research and Development Center (FCRDC), and this award expands and strengthens that collaboration by converting the current onsite staffing contract into a long-term dedicated space agreement. In support of the new contract, Charles River will construct a shared-use facility to provide research model production and related services to NCI-FCRDC, addressing NCI’s current and future research support needs.
